D. Devanand, Xinhua Liu, M. Tabert, Gnanavalli Pradhaban, K. Cuasay, K. Bell, M. Leon, R. Doty, Y. Stern, G. Pelton (2008)
Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseBiological Psychiatry, 64
O. Hansson, H. Zetterberg, Peder Buchhave, E. Londos, K. Blennow, L. Minthon (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 5
P. Vemuri, H. Wiste, S. Weigand, L. Shaw, J. Trojanowski, M. Weiner, D. Knopman, R. Petersen, C. Jack (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjectsNeurology, 73
M. Leon, M. Leon, S. Desanti, Ray Zinkowski, Pankaj Mehta, Domenico Praticò, S. Segal, H. Rusinek, Jinyu Li, W. Tsui, W. Tsui, L. Louis, Christopher Clark, C. Tarshish, Yi Li, L. Lair, Elizabeth Javier, Kenneth Rich, P. Lesbre, Lisa Mosconi, B. Reisberg, Marcin Sadowski, J. DeBernadis, D. Kerkman, Harald Hampel, L. Wahlund, Peter Davies (2006)
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentNeurobiology of Aging, 27
Lei Wang, Ali Khan, J. Csernansky, B. Fischl, M. Miller, J. Morris, M. Beg (2009)
Fully‐automated, multi‐stage hippocampus mapping in very mild Alzheimer diseaseHippocampus, 19
K. Ritchie, S. Artero, J. Touchon (2001)
Classification criteria for mild cognitive impairmentNeurology, 56
N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S. Herukka, W. Flier, M. Blankenstein, M. Ewers, Kenneth Rich, E. Kaiser, M. Verbeek, M. Tsolaki, E. Mulugeta, E. Rosén, D. Aarsland, P. Visser, J. Schröder, J. Marcusson, M. Leon, H. Hampel, P. Scheltens, T. Pirttilä, A. Wallin, M. Jönhagen, L. Minthon, B. Winblad, K. Blennow (2009)
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.JAMA, 302 4
J. Morris, A. Heyman, R. Mohs, J. Hughes, G. Belle, G. Fillenbaum, E. Mellits, C. Clark (1989)
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's diseaseNeurology, 39
S. Herukka, S. Helisalmi, M. Hallikainen, Susanna Tervo, H. Soininen, T. Pirttilä (2007)
CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.Neurobiology of aging, 28 4
N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L. Shaw, J. Trojanowski, P. Thompson, C. Jack, M. Weiner (2008)
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkersBrain, 132
E. Kaplan, H. Goodglass, Sandra Weintraub, Osa Segal (2001)
Boston Naming Test
P. Visser, F. Verhey, D. Knol, P. Scheltens, L. Wahlund, Y. Freund-Levi, M. Tsolaki, L. Minthon, Å. Wallin, H. Hampel, K. Bürger, T. Pirttila, H. Soininen, M. Rikkert, M. Verbeek, L. Spiru, K. Blennow (2009)
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort studyThe Lancet Neurology, 8
L. Shaw, H. Vanderstichele, M. Knapik-Czajka, C. Clark, P. Aisen, R. Petersen, K. Blennow, H. Soares, A. Simon, P. Lewczuk, R. Dean, E. Siemers, W. Potter, V. Lee, J. Trojanowski (2009)
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 65
T. Tapiola, C. Pennanen, Mia Tapiola, Susanna Tervo, M. Kivipelto, T. Hänninen, M. Pihlajamäki, M. Laakso, M. Hallikainen, Anne Hämäläinen, M. Vanhanen, E. Helkala, R. Vanninen, A. Nissinen, R. Rossi, G. Frisoni, H. Soininen (2008)
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up studyNeurobiology of Aging, 29
L. Rozzini, B. Chilovi, M. Conti, E. Bertoletti, I. Delrio, M. Trabucchi, A. Padovani (2007)
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deteriorationInternational Journal of Geriatric Psychiatry, 22
M. Schemper (2003)
Predictive accuracy and explained variationStatistics in Medicine, 22
A. Du, N. Schuff, N. Schuff, D. Amend, M. Laakso, Y. Hsu, W. Jagust, K. Yaffe, J. Kramer, B. Reed, D. Norman, H. Chui, M. Weiner, M. Weiner (2001)
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 71
J. Morris, R. Mohs, H. Rogers, G. Fillenbaum, A. Heyman (2002)
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.Psychopharmacology bulletin, 24 4
A. Wimo, G. Ljunggren, B. Winblad (1997)
Costs of dementia and dementia care: a reviewInternational Journal of Geriatric Psychiatry, 12
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (2011)
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseNeurology, 77
R. Frank, D. Galasko, H. Hampel, J. Hardy, M. Leon, P. Mehta, J. Rogers, E. Siemers, J. Trojanowski (2003)
Biological markers for therapeutic trials in Alzheimer’s disease Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer’s diseaseNeurobiology of Aging, 24
F. Bouwman, S. Schoonenboom, W. Flier, E. Elk, A. Kok, F. Barkhof, M. Blankenstein, P. Scheltens (2007)
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentNeurobiology of Aging, 28
D. Jacobs, M. Sano, G. Dooneief, K. Marder, K. Bell, Y. Stern (1995)
Neuropsychological detection and characterization of preclinical Alzheimer's diseaseNeurology, 45
M. Tierney, J. Szalai, W. Snow, R. Fisher, A. Nores, G. Nadon, E. Dunn, P. George-hyslop (1996)
Prediction of probable Alzheimer's disease in memory-impaired patientsNeurology, 46
C. Reynolds, J. Powel (1988)
Wechsler memory scale-revisedArchives of Clinical Neuropsychology, 3
R. Terry, P. Davies (1980)
Dementia of the Alzheimer type.Annual review of neuroscience, 3
C. Fennema-Notestine, D. Hagler, L. McEvoy, A. Fleisher, Elaine Wu, D. Karow, A. Dale (2009)
Structural MRI biomarkers for preclinical and mild Alzheimer's diseaseHuman Brain Mapping, 30
P. Rubé (1959)
L’examen Clinique en PsychologieAmerican Journal of Psychotherapy, 13
K. Blennow, H. Hampel (2003)
CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2
M. Tabert, J. Manly, Xinhua Liu, G. Pelton, S. Rosenblum, M. Jacobs, D. Zamora, Madeleine Goodkind, K. Bell, Y. Stern, D. Devanand (2006)
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.Archives of general psychiatry, 63 8
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
C. Pennanen, M. Kivipelto, Susanna Tuomainen, P. Hartikainen, T. Hänninen, M. Laakso, M. Hallikainen, M. Vanhanen, A. Nissinen, E. Helkala, P. Vainio, R. Vanninen, K. Partanen, H. Soininen (2004)
Hippocampus and entorhinal cortex in mild cognitive impairment and early ADNeurobiology of Aging, 25
P. Petersen, MD Smith, PhD Waring, PhD Ivnik, PhD Tangalos, MD Kokmen (1999)
Mild Cognitive Impairment Clinical Characterization and Outcome
B. Fischl, D. Salat, E. Busa, M. Albert, M. Dieterich, C. Haselgrove, A. Kouwe, R. Killiany, D. Kennedy, Shuna Klaveness, A. Montillo, N. Makris, B. Rosen, A. Dale (2002)
Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human BrainNeuron, 33
D. Devanand, Gnanavalli Pradhaban, Xinhua Liu, A. Khandji, S. Santi, S. Segal, H. Rusinek, G. Pelton, L. Honig, R. Mayeux, Y. Stern, M. Tabert, M. Leon (2007)
Hippocampal and entorhinal atrophy in mild cognitive impairmentNeurology, 68
K. Kantarci, C. Jack (2003)
Neuroimaging in Alzheimer disease: an evidence-based review.Neuroimaging clinics of North America, 13 2
D. Broshek, J. Barth (2000)
The Halstead-Reitan Neuropsychological Test Battery.
G. Frisoni, R. Ganzola, E. Canu, U. Rüb, F. Pizzini, F. Alessandrini, G. Zoccatelli, A. Beltramello, C. Caltagirone, P. Thompson (2008)
Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.Brain : a journal of neurology, 131 Pt 12
S. Herukka, S. Helisalmi, M. Hallikainen, Susanna Tervo, H. Soininen, T. Pirttilä (2007)
CSF Aβ42, Tau and phosphorylated Tau, APOE ɛ4 allele and MCI type in progressive MCINeurobiology of Aging, 28
C. Jack, M. Bernstein, Nick Fox, Paul Thompson, G. Alexander, D. Harvey, B. Borowski, P. Britson, Jennifer Whitwell, C. Ward, A. Dale, J. Felmlee, J. Gunter, D. Hill, R. Killiany, N. Schuff, Sabrina Fox‐Bosetti, Chen Lin, C. Studholme, C. DeCarli, G. Krueger, H. Ward, G. Metzger, K. Scott, R. Mallozzi, D. Blezek, J. Levy, J. Debbins, A. Fleisher, M. Albert, R. Green, G. Bartzokis, G. Glover, J. Mugler, M. Weiner (2008)
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 27
K. Arbuthnott, J. Frank (2000)
Trail Making Test, Part B as a Measure of Executive Control: Validation Using a Set-Switching ParadigmJournal of Clinical and Experimental Neuropsychology, 22
J. Csernansky, Lei Wang, S. Joshi, J. Miller, M. Gado, D. Kido, D. McKeel, J. Morris, Michael Miller (2000)
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampusNeurology, 55
M. Tierney, Christie Yao, A. Kiss, I. Mcdowell (2005)
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 yearsNeurology, 64
M. Brys, E. Pirraglia, Kenneth Rich, S. Rolstad, Lisa Mosconi, Remigiusz Switalski, L. Glodzik-Sobanska, S. Santi, R. Zinkowski, P. Mehta, D. Praticò, L. Louis, A. Wallin, K. Blennow, M. Leon (2009)
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairmentNeurobiology of Aging, 30
C. Jack, R. Petersen, Yuecheng Xu, P. O'Brien, Glenn Smith, R. Ivnik, B. Boeve, S. Waring, E. Tangalos, E. Kokmen (1999)
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairmentNeurology, 52
B. Dubois, H. Feldman, C. Jacova, S. DeKosky, P. Barberger‐Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, John O'Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P. Visser, P. Scheltens (2007)
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 6
L. Bäckman, Sari Jones, A. Berger, E. Laukka, B. Small (2005)
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.Neuropsychology, 19 4
S. Landau, D. Harvey, Cindee Madison, E. Reiman, N. Foster, P. Aisen, R. Petersen, L. Shaw, J. Trojanowski, C. Jack, M. Weiner, W. Jagust (2010)
Comparing predictors of conversion and decline in mild cognitive impairmentNeurology, 75
M. Sarazin, C. Berr, J. Rotrou, C. Fabrigoule, F. Pasquier, S. Legrain, B. Michel, M. Puel, M. Volteau, J. Touchon, M. Verny, B. Dubois (2007)
Amnestic syndrome of the medial temporal type identifies prodromal ADNeurology, 69
A. Fleisher, S. Sun, C. Taylor, C. Ward, A. Gamst, R. Petersen, C. Jack, P. Aisen, L. Thal (2008)
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairmentNeurology, 70
P. Vemuri, J. Gunter, M. Senjem, J. Whitwell, K. Kantarci, D. Knopman, B. Boeve, R. Petersen, C. Jack (2008)
Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studiesNeuroImage, 39
B. Schmand, H. Huizenga, A. GoolvanW. (2009)
Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's diseasePsychological Medicine, 40
S. Herukka, M. Hallikainen, H. Soininen, T. Pirttilä (2005)
CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairmentNeurology, 64
M. Ewers, K. Buerger, S. Teipel, P. Scheltens, J. Schröder, R. Zinkowski, F. Bouwman, P. Schönknecht, N. Schoonenboom, N. Andreasen, A. Wallin, J. Debernardis, D. Kerkman, B. Heindl, K. Blennow, H. Hampel (2007)
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCINeurology, 69
M. Brys, Lidia Glodzik, Lisa Mosconi, Remigiusz Switalski, S. Santi, E. Pirraglia, Kenneth Rich, Byeong-Chae Kim, P. Mehta, R. Zinkowski, D. Praticò, A. Wallin, H. Zetterberg, W. Tsui, H. Rusinek, K. Blennow, M. Leon (2009)
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.Journal of Alzheimer's disease : JAD, 16 2
Neurobiology of Aging – Unpaywall
Published: Dec 15, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.